Impact of menopausal status and HER-2/neu protein on efficacy of EGFR-TKI in EGFR mutant patients with non-small cell lung cancer

Clinical studies have confirmed epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) used in lung cancer patients with EGFR mutations can obtain a better result, but still part of the patients with poor efficacy. EGFR mutation is highly related to female, nonsmoking and adenocar...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Zi-Jun, Tu, Hai-Yan, Fu, Ming, Zhong, Wen-Zhao, An, She-Juan, Yan, Hong-Hong, Chen, Hua-Jun, Lin, Hui-Ran, Wu, Yi-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134809/
https://www.ncbi.nlm.nih.gov/pubmed/30210620
http://dx.doi.org/10.7150/jca.25679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134809/
https://www.ncbi.nlm.nih.gov/pubmed/30210620
http://dx.doi.org/10.7150/jca.25679

Ejemplares similares